Identifying unmet clinical needs for diagnostics in AMR
The NIHR Diagnostic Evidence Co-operative Oxford in collaboration with NIHR DEC Leeds and the Knowledge Transfer Network (KTN) are delighted to be hosting a clinician/industry workshop on diagnostic solutions for antimicrobial resistance (AMR).
The aim of this workshop is to outline the clinical need for AMR-relevant diagnostic tests, to consider the clinical and system barriers to their implementation and to stimulate new collaborative approaches.
In May 2016, the UK Government-commissioned Review on Antimicrobial Resistance set out the scale of the crisis directly affecting the health of the world’s population through the evolution of drug resistance mechanisms in pathogenic microorganisms and indirectly through the threat posed to our food chain from resistance (agriculture and aquaculture). The report estimated a global impact attributable to AMR of approximately 10 million lives lost per year by 2050 if the problem is not addressed.
Of vital importance for improved antimicrobial stewardship is the availability of reliable diagnostic technologies for use by frontline clinicians. The crux of the diagnostic problem facing healthcare workers is how to safely and effectively stratify bacterial and viral infections, and to identify antibiotic resistance, so that the most appropriate treatment can be delivered in a timely manner.
There is currently a paucity of AMR-relevant diagnostics for use by clinicians, with those that are available not being widely implemented.
Bookings are by invitation only; please check back for updates and draft programme.
Location: St Hugh's College, St Margaret’s Road, Oxford OX2 6LE
• Professor Christopher Butler (University of Oxford) UTI diagnostics
• Professor Rosanna Peeling (London School of Hygiene & Tropical Medicine) Global Health Diagnostics
• Dr Till Bachmann (University of Edinburgh) European diagnostics initiatives
• Professor Alastair Hay (University of Bristol) Paediatric respiratory pathogens
• Professor Michael Moore (University of Southampton) Respiratory prescribing
• Sarah Wallis Deputy Chair, BIVDA AMR Working Party and Sales Support & Marketing Manager, MAST Group
• Dr Eddie Blair Integrated Medicines limited (IML)
• Professor Paul Dark, University of Manchester
• Mandy Campbell, HORIBA UK Ltd